Saturday, July 11, 2020
wellness India Expo
Home Tags Sclerosis

Tag: Sclerosis

DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung...

Being the first and only approved treatment option available for people living with SSc-ILD, the approval constitutes a breakthrough in an area of high unmet need. Following the FDA’s approval in September 2019, Nintedanib in SSc-ILD has so far been approved in 15 countries including the European Union, Canada, Japan and Brazil.................

Monoclonal antibodies to dominate global multiple sclerosis drugs market

Dominance of the segment is likely to be attributed to the launch of new monoclonal antibody products for the treatment of multiple sclerosis, including Ofatumumab and Ublituximab, during the forecast period.....................

Proposal to include Multiple Sclerosis in Ayushman Bharat under consideration

If the Multiple Sclerosis along with 20 other disabilities is included in the Aayushmaan Bharat – Health Insurance Scheme, the MS patients can avail the central government’s health scheme to be self-reliant to an extent..................